Imane Abou Dalle (Iman Abou Dalle)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Peritoneal Dialysis

Newly Diagnosed

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

American journal of hematology

Clinical hematology international

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Jean El-Cheikh, Ghassan Bidaoui, Ali Atoui, Khodr Terro, Layal Sharrouf, Ammar Zahreddine, Nour Moukalled, Imane Abou Dalle, Ali Bazarbachi, Florent Malard, Rémy Duléry
Clofarabine and total body irradiation (TBI) as conditioning regimen for allogeneic stem cell transplantation in high-risk acute leukemia patients: a two-center retrospective cohort study. Bone marrow transplantation (2023)
Mona Ali Hassan, Nour Moukalled, Jean El Cheikh, Ali Bazarbachi, Imane Abou Dalle
Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia. Clinical hematology international (2023)
Imane Abou Dalle, Myriam Labopin, Nicolaus M Kröger, Thomas Schroeder, Juergen Finke, Matthias Stelljes, Andreas Neubauer, Didier Blaise, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Edouard Forcade, Maija Itäla-Remes, Peter Dreger, Gesine Bug, Jakob Passweg, Michael Heuser, Goda Choi, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Ali Bazarbachi, Florent Malard
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2023)
Ali Ibrahim, Nour Moukalled, Rami Mahfouz, Jean El Cheikh, Ali Bazarbachi, Imane Abou Dalle
Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia. Clinical hematology international 4 (1-2) (2022)
Imane Abou Dalle, Hagop M Kantarjian, Farhad Ravandi, Naval G Daver, Xuemei Wang, Elias J Jabbour, Zeev Estrov, Courtney D D DiNardo, Naveen Pemmaraju, Alessandra Ferrajoli, Nitin Jain, Sa A Wang, Nadya J Jammal, Gautam Borthakur, Kiran Naqvi, Sarah Pelletier, Sherry Pierce, Michael Andreeff, Guillermo Garcia Manero, Jorge E Cortes, Tapan Mahendra Kadia
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission. Cancer 127 (11) (2021)
Imane Abou Dalle, Ahmad Ghorab, Keyur Patel, Xuemei Wang, Hyunsoo Hwang, Jorge Cortes, Ghayas C Issa, Fevzi Yalniz, Koji Sasaki, Dai Chihara, Allyson Price, Tapan Kadia, Naveen Pemmaraju, Naval Daver, Courtney D D DiNardo, Farhad Ravandi, Hagop M Kantarjian, Gautam Borthakur
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia. Blood cancer journal 10 (5) (2020)
Imane Abou Dalle, Hagop M Kantarjian, Jan Burger, Zeev E Estrov, Maro Ohanian, Srdan Verstovsek, Farhad Ravandi, Gautam Borthakur, Guillermo Garcia-Manero, Elias Jabbour, Jorge Cortes
Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States. Cancer medicine 8 (15) (2019)
Imane Abou Dalle, Hagop M Kantarjian, Nicholas James Short, Marina Konopleva, Nitin Jain, Guillermo Garcia-Manero, Rebecca Garris, Wei Qiao, Jorge E Cortes, Susan O'Brien, Partow Kebriaei, Tapan Kadia, Elias J Jabbour, Farhad Ravandi
Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors. American journal of hematology 94 (12) (2019)
Imane Abou Dalle, Hagop M Kantarjian, Sarah A Bannon, Rashmi Kanagal-Shamana, Mark Routbort, Keyur P Patel, Shimin Hu, Kapil Bhalla, Guillermo Garcia-Manero, Courtney D D DiNardo
Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation. American journal of hematology 95 (2) (2019)
Fevzi F Yalniz, Imane Abou Dalle, Hagop M Kantarjian, Gautam Borthakur, Tapan Mahendra Kadia, Keyur Patel, Sanam Loghavi, Guillermo Garcia-Manero, Koji Sasaki, Naval G Daver, Courtney D D DiNardo, Naveen Pemmaraju, Nicholas James Short, Musa Ylimaz, Prithviraj Bose, Kiran Naqvi, Sherry Pierce, Graciela M Nogueras González, Marina Konopleva, Michael Andreeff, Jorge E Cortes, Farhad Ravandi
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib. American journal of hematology 94 (9) (2019)